These 4 Measures Indicate That Option Care Health (NASDAQ:OPCH) Is Using Debt Reasonably Well
UBS Initiates Option Care Health(OPCH.US) With Hold Rating, Announces Target Price $26
Critical Insights From Option Care Health Analyst Ratings: What You Need To Know
Option Care Health Initiated at Neutral by UBS
UBS Initiates Coverage On Option Care Health With Neutral Rating, Announces Price Target of $26
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
Great Week for Option Care Health, Inc. (NASDAQ:OPCH) Institutional Investors After Losing 20% Over the Previous Year
Option Care Health (OPCH) Gets a Buy From Truist Financial
Option Care Health Management to Meet With Truist
Jefferies Maintains Option Care Health(OPCH.US) With Hold Rating, Maintains Target Price $26
Jefferies Remains a Hold on Option Care Health (OPCH)
Express News | Option Care Health Inc : JP Morgan Cuts Target Price to $38 From $42
Independent Non Executive Chairman of the Board of Option Care Health Picks Up 15% More Stock
Option Care Health, Inc.'s (NASDAQ:OPCH) Popularity With Investors Under Threat As Stock Sinks 27%
Option Care Health Insider Bought Shares Worth $969,031, According to a Recent SEC Filing
UnitedHealth's Effort to Buy Another Home Health Provider at Risk Amid DOJ Lawsuit
Those Who Invested in Option Care Health (NASDAQ:OPCH) Five Years Ago Are up 74%
Option Care Health to Participate in Upcoming Investor Conferences
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Goldman Shifts Option Care Health to Neutral, Cites Looming Profit Concerns